GK Partners ApS 4
4 · Nordicus Partners Corp · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Gk Partners ApS
10% Owner
Transactions
- Other
Common stock
2024-11-12+1,076,412→ 3,349,568 total - Purchase
Common stock
2024-09-03$10.00/sh+500$5,000→ 2,245,956 total - Purchase
Common stock
2024-10-01$10.00/sh+5,000$50,000→ 2,250,956 total - Exercise Out-of-Money
Warrant
2024-08-30$10.00/sh+3,400$34,000→ 532,500 totalExercise: $10.00From: 2022-04-01Exp: 2023-12-31→ Common stock (600,000 underlying) - Exercise Out-of-Money
Warrant
2024-10-03$10.00/sh+3,200$32,000→ 529,300 totalExercise: $10.00From: 2022-04-01Exp: 2023-12-31→ Common stock (600,000 underlying) - Exercise Out-of-Money
Warrant
2024-11-01$10.00/sh+3,500$35,000→ 513,800 totalExercise: $10.00From: 2022-04-01Exp: 2023-12-31→ Common stock (600,000 underlying) - Exercise Out-of-Money
Warrant
2024-10-17$10.00/sh+12,000$120,000→ 517,300 totalExercise: $10.00From: 2022-04-01Exp: 2023-12-31→ Common stock (600,000 underlying) - Exercise Out-of-Money
Warrant
2024-11-06$10.00/sh+3,500$35,000→ 510,300 totalExercise: $10.00From: 2022-04-01Exp: 2023-12-31→ Common stock (600,000 underlying)
Footnotes (1)
- [F1]Shares acquired in connection with the acquisition by Nordicus Partners Corporation through a share exchange with the shareholders of Bio-Convert ApS (893,268 shares) and in connection with the acquisition by Nordicus Partners Corporation of Orocidin A/S (183,144 shares) on November 12, 2024.